Milestone Pharmaceuticals Inc.
MIST
$2.15
$0.073.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.05% | 37.55% | -67.93% | -30.98% | -0.81% |
| Total Depreciation and Amortization | -10.71% | 3.70% | -95.24% | 2,168.00% | -3.85% |
| Total Amortization of Deferred Charges | 2.83% | 3.92% | 5.15% | 2.11% | 4.40% |
| Total Other Non-Cash Items | -2.04% | 2.38% | 28.47% | -21.79% | 1.36% |
| Change in Net Operating Assets | 96.34% | -141.23% | 42.19% | 1,447.60% | -81.56% |
| Cash from Operations | 22.43% | 9.93% | -103.89% | 2.49% | -15.94% |
| Capital Expenditure | 81.82% | -83.33% | 72.73% | -450.00% | 42.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -451.40% | -70.36% | 73.53% | 198.47% | -31.66% |
| Cash from Investing | -451.81% | -70.39% | 73.70% | 198.32% | -31.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 128,636.11% | -74.29% | 483.33% | -67.57% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 135,783.33% | -74.29% | 483.33% | -67.57% | 124.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 261.87% | -113.08% | 57.98% | 2,803.02% | -114.79% |